Inflammatory cardiovascular risk markers in obstructive sleep apnoea syndrome

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 7, Issue 1, 2009, Pages 76-81

  Ryan, Silke ^a,b   McNicholas, Walter T ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cardiovascular disease; Inflammation; Intermittent hypoxia; Obstructive sleep apnoea syndrome

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; SELECTIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL CONSUMPTION; APNEA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; EXERCISE; HUMAN; INFLAMMATION; LEUKOCYTE; MONOCYTE; MORBIDITY; MORTALITY; NONHUMAN; OBESITY; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; REVIEW; SLEEP APNEA SYNDROME; SMOKING; T LYMPHOCYTE; BLOOD; RISK FACTOR;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 64149129175     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152509787047685     Document Type: Review

References (89)

1. Guilleminault, C.; Tilkian, A.; Dement, W.C. The sleep apnea syndromes. Annu. Rev. Med., 1976, 27, 465.
2. Sullivan, C.E.; Issa, F.G.; Berthon-Jones, M.; Eves, L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet, 1981, 1(8225), 862.
3. Young, T.; Palta, M.; Dempsey, J.; Skatrud, J.; Weber, S.; Badr, S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med., 1993, 328, 1230.
4. Engleman, H.M.; Douglas, N.J. Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax, 2004, 59, 618.
5. Stoohs, R.A.; Bingham, L.A.; Itoi, A.; Guilleminault, C.; Dement, W.C. Sleep and sleep-disordered breathing in commercial long-haul truck drivers. Chest, 1995, 107, 1275.
6. McNicholas, W.T.; Bonsigore, M.R. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur. Respir. J., 2007, 29, 156.
7. Kiely, J.L.; McNicholas, W.T. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur. Respir. J., 2000, 16, 128.
8. Nieto, F.J.; Young, T.B.; Lind, B.K.; Shahar, E.; Samet, J.M.; Redline, S.; D'Agostino, R.B.; Newman, A.B.; Lebowitz, M.D.; Pickering, T.G. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. JAMA, 2000, 283, 1829.
9. Young, T.; Peppard, P.; Palta, M.; Hla, K.M.; Finn, L.; Morgan, B.; Skatrud, J. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch. Intern. Med., 1997, 157, 1746.
10. Peppard, P.E.; Young, T.; Palta, M.; Skatrud, J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med., 2000, 342, 1378.
11. Shahar, E.; Whitney, C.W.; Redline, S.; Lee, E.T.; Newman, A.B.; Javier Nieto, F.; O'Connor, G.T.; Boland, L.L.; Schwartz, J.E.; Samet, J.M. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med., 2001, 163, 19.
12. Peker, Y.; Hedner, J.; Norum, J.; Kraiczi, H.; Carlson, J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am. J. Respir Crit. Care Med., 2002, 166, 159.
13. Doherty, L.S.; Kiely, J.L.; Swan, V.; McNicholas, W.T. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest, 2005, 127, 2076.
14. Marin, J.M.; Carrizo, S.J.; Vicente, E.; Agusti, A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 2005, 365, 1046.
15. Ross, R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med., 1999, 340, 115.
16. Libby, P. Inflammation in atherosclerosis. Nature, 2002, 420, 868.
17. Blake, G.J.; Ridker, P.M. Inflammatory bio-markers and cardiovascular risk prediction. J. Intern. Med., 2002, 252, 283.
18. Glass, C.K.; Witztum, J.L. Atherosclerosis. the road ahead. Cell, 2001, 104, 503.
19. Lusis, A.J. Atherosclerosis. Nature, 2000, 407, 233.
20. Willerson, J.T.; Ridker, P.M. Inflammation as a cardiovascular risk factor. Circulation, 2004, 109, II2.
21. Pasceri, V.; Willerson, J.T.; Yeh, E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 2000, 102, 2165.
22. Nacher, M.; Serrano-Mollar, A.; Farre, R.; Panes, J.; Segui, J.; Montserrat, J.M. Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir. Physiol. Neurobiol., 2007, 155, 93.
23. Dyugovskaya, L.; Lavie, P.; Lavie, L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann. NY Acad. Sci., 2005, 1051, 340.
24. Dyugovskaya, L.; Lavie, P.; Hirsh, M.; Lavie, L. Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur. Respir. J., 2005, 25, 820.
25. Dyugovskaya, L.; Lavie, P.; Lavie, L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am. J. Respir. Crit. Care Med., 2003, 168, 242.
26. Dyugovskaya, L.; Lavie, P.; Lavie, L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am. J. Respir. Crit. Care Med., 2002, 165, 934.
27. Ryan, S.; Taylor, C.T.; McNicholas, W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation, 2005, 112, 2660.
28. Greenberg, H.; Ye, X.; Wilson, D.; Htoo, A.K.; Hendersen, T.; Liu, S.F. Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem. Biophys. Res. Commun., 2006, 343, 591.
29. Yamauchi, M.; Tamaki, S.; Tomoda, K.; Yoshikawa, M.; Fukuoka, A.; Makinodan, K.; Koyama, N.; Suzuki, T.; Kimura, H. Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep Breath, 2006, 10, 189.
30. Ryan, S.; McNicholas, W.T.; Taylor, C.T. A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation. Biochem. Biophys. Res. Commun., 2007, 355, 728.
31. Goldbart, A.; Row, B.W.; Kheirandish, L.; Schurr, A.; Gozal, E.; Guo, S.Z.; Payne, R.S.; Cheng, Z.; Brittian, K.R.; Gozal, D. Intermittent hypoxic exposure during light phase induces changes in cAMP response element binding protein activity in the rat CA1 hippocampal region: water maze performance correlates. Neuroscience, 2003, 122, 585.
32. Pasceri, V.; Cheng, J.S.; Willerson, J.T.; Yeh, E.T. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation, 2001, 103, 2531.
33. Ridker, P.M.; Cushman, M.; Stampfer, M.J.; Tracy, R.P.; Hennekens, C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med., 1997, 336, 973.
34. Ridker, P.M.; Buring, J.E.; Shih, J.; Matias, M.; Hennekens, C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation, 1998, 98, 731.
35. Koenig, W.; Sund, M.; Frohlich, M.; Fischer, H.G.; Lowel, H.; Doring, A.; Hutchinson, W.L.; Pepys, M.B. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation, 1999, 99, 237.
36. Heeschen, C.; Hamm, C.W.; Bruemmer, J.; Simoons, M.L. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J. Am. Coll. Cardiol., 2000, 35, 1535.
37. Haverkate, F.; Thompson, S.G.; Pyke, S.D.; Gallimore, J.R.; Pepys, M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet, 1997, 349, 462.
38. Liuzzo, G.; Biasucci, L.M.; Gallimore, J.R.; Grillo, R.L.; Rebuzzi, A.G.; Pepys, M.B.; Maseri, A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N. Engl. J. Med., 1994, 331, 417.
39. Miller, M.; Zhan, M.; Havas, S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch. Intern. Med., 2005, 165, 2063.
40. Khera, A.; de Lemos, J.A.; Peshock, R.M.; Lo, H.S.; Stanek, H.G.; Murphy, S.A.; Wians, F.H., Jr.; Grundy, S.M.; McGuire, D.K. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation, 2006, 113, 38.
41. Cao, J.J.; Arnold, A.M.; Manolio, T.A.; Polak, J.F.; Psaty, B.M.; Hirsch, C. H.; Kuller, L.H.; Cushman, M. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation, 2007, 116, 32.
42. Yudkin, J.S.; Stehouwer, C.D.; Emeis, J.J.; Coppack, S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol., 1999, 19, 972.
43. Visser, M.; Bouter, L.M.; McQuillan, G.M.; Wener, M.H.; Harris, T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA, 1999, 282, 2131.
44. Yao, M.; Tachibana, N.; Okura, M.; Ikeda, A.; Tanigawa, T.; Yamagishi, K.; Sato, S.; Shimamoto, T.; Iso, H. The relationship between sleep-disordered breathing and high-sensitivity C-reactive protein in Japanese men. Sleep, 2006, 29, 661.
45. Taheri, S.; Austin, D.; Lin, L.; Nieto, F.J.; Young, T.; Mignot, E. Correlates of serum C-reactive protein (CRP) - no association with sleep duration or sleep disordered breathing. Sleep, 2007, 30, 991.
46. Shamsuzzaman, A.S.; Winnicki, M.; Lanfranchi, P.; Wolk, R.; Kara, T.; Accurso, V.; Somers, V.K. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation, 2002, 105, 2462.
47. Yokoe, T.; Minoguchi, K.; Matsuo, H.; Oda, N.; Minoguchi, H.; Yoshino, G.; Hirano, T.; Adachi, M. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation, 2003, 107, 1129.
48. Saletu, M.; Nosiska, D.; Kapfhammer, G.; Lalouschek, W.; Saletu, B.; Benesch, T.; Zeitlhofer, J. Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA) Association of mild OSA with early atherosclerosis. J. Neurol., 2006, 253, 746.
49. Hayashi, M.; Fujimoto, K.; Urushibata, K.; Takamizawa, A.; Kinoshita, O.; Kubo, K. Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome. Respirology, 2006, 11, 24.
50. Can, M.; Acikgoz, S.; Mungan, G.; Bayraktaroglu, T.; Kocak, E.; Guven, B.; Demirtas, S. Serum cardiovascular risk factors in obstructive sleep apnea. Chest, 2006, 129, 233.
51. Kokturk, O.; Ciftci, T.U.; Mollarecep, E.; Ciftci, B. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int. Heart J., 2005, 46, 801.
52. Barcelo, A.; Barbe, F.; Llompart, E.; Mayoralas, L.R.; Ladaria, A.; Bosch, M.; Agusti, A.G. Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am. J. Med., 2004, 117, 118.
53. Guilleminault, C.; Kirisoglu, C.; Ohayon, M.M. C-reactive protein and sleep-disordered breathing. Sleep, 2004, 27, 1507.
54. Ryan, S.; Nolan, G.M.; Hannigan, E.; Cunningham, S.; Taylor, C.; McNicholas, W.T. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax, 2007, 62, 509.
55. Chung, S.; Yoon, I.Y.; Shin, Y.K.; Lee, C.H.; Kim, J.W.; Lee, T.; Choi, D.J.; Ahn, H.J. Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome. Sleep, 2007, 30, 997.
56. Akashiba, T.; Akahoshi, T.; Kawahara, S.; Majima, T.; Horie, T. Effects of long-term nasal continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea syndrome. Intern. Med., 2005, 44, 899.
57. Steiropoulos, P.; Tsara, V.; Nena, E.; Fitili, C.; Kataropoulou, M.; Froudarakis, M.; Christaki, P.; Bouros, D. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest, 2007, 132, 843.
58. Kritchevsky, S.B.; Cesari, M.; Pahor, M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc. Res., 2005, 66, 265.
59. Skoog, T.; Dichtl, W.; Boquist, S.; Skoglund-Andersson, C.; Karpe, F.; Tang, R.; Bond, M.G.; de Faire, U.; Nilsson, J.; Eriksson, P.; Hamsten, A. Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur. Heart J., 2002, 23, 376.
60. Cesari, M.; Penninx, B.W.; Newman, A.B.; Kritchevsky, S.B.; Nicklas, B.J.; Sutton-Tyrrell, K.; Rubin, S.M.; Ding, J.; Simonsick, E.M.; Harris, T.B.; Pahor, M. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation, 2003, 108, 2317.
61. Ridker, P.M.; Rifai, N.; Pfeffer, M.; Sacks, F.; Lepage, S.; Braunwald, E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation, 2000, 101, 2149.
62. Ciftci, T.U.; Kokturk, O.; Bukan, N.; Bilgihan, A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine, 2004, 28, 87.
63. Minoguchi, K.; Tazaki, T.; Yokoe, T.; Minoguchi, H.; Watanabe, Y.; Yamamoto, M.; Adachi, M. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest, 2004, 126, 1473.
64. Ryan, S.; Taylor, C.T.; McNicholas, W.T. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med., 2006, 174, 824.
65. Vgontzas, A.N.; Papanicolaou, D.A.; Bixler, E.O.; Kales, A.; Tyson, K.; Chrousos, G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab., 1997, 82, 1313.
66. Vgontzas, A.N.; Zoumakis, E.; Lin, H.M.; Bixler, E.O.; Trakada, G.; Chrousos, G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab., 2004, 89, 4409.
67. Luc, G.; Bard, J.M.; Juhan-Vague, I.; Ferrieres, J.; Evans, A.; Amouyel, P.; Arveiler, D.; Fruchart, J.C.; Ducimetiere, P. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 1255.
68. Harris, T.B.; Ferrucci, L.; Tracy, R.P.; Corti, M.C.; Wacholder, S.; Ettinger, W.H., Jr.; Heimovitz, H.; Cohen, H.J.; Wallace, R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med., 1999, 106, 506.
69. Biasucci, L.M.; Vitelli, A.; Liuzzo, G.; Altamura, S.; Caligiuri, G.; Monaco, C.; Rebuzzi, A.G.; Ciliberto, G.; Maseri, A. Elevated levels of interleukin-6 in unstable angina. Circulation, 1996, 94, 874.
70. Mohamed-Ali, V.; Goodrick, S.; Rawesh, A.; Katz, D.R.; Miles, J.M.; Yudkin, J.S.; Klein, S.; Coppack, S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab., 1997, 82, 4196.
71. Kanda, T.; Inoue, M.; Kotajima, N.; Fujimaki, S.; Hoshino, Y.; Kurabayashi, M.; Kobayashi, I.; Tamura, J. Circulating interleukin-6 and interleukin-6 receptors in patients with acute and recent myocardial infarction. Cardiology, 2000, 93, 191.
72. Ueda, K.; Takahashi, M.; Ozawa, K.; Kinoshita, M. Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction. Am. Heart J., 1999, 138, 908.
73. Gerszten, R.E.; Garcia-Zepeda, E.A.; Lim, Y.C.; Yoshida, M.; Ding, H.A.; Gimbrone, M.A., Jr.; Luster, A.D.; Luscinskas, F.W.; Rosenzweig, A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature, 1999, 398, 718.
74. Aukrust, P.; Yndestad, A.; Smith, C.; Ueland, T.; Gullestad, L.; Damas, J.K. Chemokines in cardiovascular risk prediction. Thromb. Haemost., 2007, 97, 748.
75. Boekholdt, S.M.; Peters, R.J.; Hack, C.E.; Day, N.E.; Luben, R.; Bingham, S.A.; Wareham, N.J.; Reitsma, P.H.; Khaw, K.T. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 1503.
76. Romuk, E.; Skrzep-Poloczek, B.; Wojciechowska, C.; Tomasik, A.; Birkner, E.; Wodniecki, J.; Gabrylewicz, B.; Ochala, A.; Tendera, M. Selectin-P and interleukin-8 plasma levels in coronary heart disease patients. Eur. J. Clin. Invest., 2002, 32, 657.
77. Alzoghaibi, M.A.; Bahammam, A.S. Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep Breath, 2005, 9, 119.
78. Ohga, E.; Tomita, T.; Wada, H.; Yamamoto, H.; Nagase, T.; Ouchi, Y. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J. Appl. Physiol., 2003, 94, 179.
79. Hwang, S.J.; Ballantyne, C.M.; Sharrett, A.R.; Smith, L.C.; Davis, C.E.; Gotto, A.M., Jr.; Boerwinkle, E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation, 1997, 96, 4219.
80. Ridker, P.M.; Buring, J.E.; Rifai, N. Soluble P-selectin and the risk of future cardiovascular events. Circulation, 2001, 103, 491.
81. Ridker, P.M.; Hennekens, C.H.; Roitman-Johnson, B.; Stampfer, M.J.; Allen, J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet, 1998, 351, 88.
82. Haim, M.; Tanne, D.; Boyko, V.; Reshef, T.; Goldbourt, U.; Leor, J.; Mekori, Y.A.; Behar, S. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. J. Am. Coll. Cardiol., 2002, 39, 1133.
83. Blankenberg, S.; Rupprecht, H.J.; Bickel, C.; Peetz, D.; Hafner, G.; Tiret, L.; Meyer, J. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation, 2001, 104, 1336.
84. Ohga, E.; Nagase, T.; Tomita, T.; Teramoto, S.; Matsuse, T.; Katayama, H.; Ouchi, Y. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J. Appl. Physiol., 1999, 87, 10.
85. El-Solh, A.A.; Mador, M.J.; Sikka, P.; Dhillon, R.S.; Amsterdam, D.; Grant, B.J. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest., 2002, 121, 1541.
86. Ursavas, A.; Karadag, M.; Rodoplu, E.; Yilmaztepe, A.; Oral, H.B.; Gozu, R.O. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration, 2007, 74, 525.
87. Zamarron-Sanz, C.; Ricoy-Galbaldon, J.; Gude-Sampedro, F.; Riveiro-Riveiro, A. Plasma levels of vascular endothelial markers in obstructive sleep apnea. Arch. Med. Res., 2006, 37, 552.
88. Chin, K.; Nakamura, T.; Shimizu, K.; Mishima, M.; Miyasaka, M.; Ohi, M. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am. J. Med., 2000, 109, 562.
89. Ridker, P.M. Role of inflammatory biomarkers in prediction of coronary heart disease. Lancet, 2001, 358, 946.